Recent Updates
Recently added Catalysts
ECOR Positive Sentiment

electroCore to Announce Fourth Quarter and Full Year Ended December 31, 2024 Financial Results on Wednesday, March 12, 2025

Thursday, March 6, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: electroCore, Inc. will announce its financial results for the fourth quarter and full year ended December 31, 2024, on March 12, 2025, after market close. The company, which specializes in bioelectronic medicine, will also host a webcast and conference call at 5:30 PM EDT for discussions on the results and to answer investor questions. This event underscores the company’s commitment to transparency and engagement with its stakeholders.
Price reaction · baseline $15.31 (2025-03-05 close) · hit after-hours · clean, no other ECOR news in the window
day 0 close
-5.4%
day 1
-7.9%
day 3 · peak
-13.9%

Market Sentiment Analysis

POSITIVE FACTORS

  • electroCore is set to announce financial results, indicating transparency.
  • The company continues to focus on health and wellness through innovative technology.
  • Webcast and conference call provide a platform for direct engagement with management.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Cash runway
~7 mo
High dilution risk
Lead asset
GammaCore
Phase 2 · Chronic Cluster Headache

Full Press Release Details

ROCKAWAY, N.J., March 06, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will report its financial results for the fourth quarter and full year ended December 31, 2024, after market close on Wednesday, March 12, 2025.
Management will host a webcast and conference call at 5:30 PM EDT to discuss the financial results and answer questions.
Conference Call & Webcast Details
Date: Wednesday, March 12, 2025
Registration: Click here to register to receive login credentials and dial-in details.
About electroCore, Inc.
electroCore, Inc. is a commercial-stage bioelectronic medicine and wellness company dedicated to improving health and promoting general wellness through its non-invasive vagus nerve stimulation (nVNS) technology platform. The company focuses on commercializing medical devices for managing and treating specific medical conditions, as well as consumer products utilizing nVNS to enhance general well-being and human performance in the United States and select international markets.
For more information, visit www.electrocore.com.

Frequently Asked Questions

When will electroCore report its financial results?

electroCore will report its financial results on March 12, 2025.

What time is the conference call on March 12, 2025?

The conference call will be at 5:30 PM EDT on March 12, 2025.

How can I register for the electroCore webcast?

You can register for the webcast to receive login credentials online.

What technology does electroCore focus on?

electroCore specializes in non-invasive vagus nerve stimulation (nVNS) technology.

What markets does electroCore serve?

electroCore operates in the U.S. and select international markets.

ShareAdd on Google
Tags: ECOR Viatris Investor Conferences Healthcare electricore bioelectronic medicine financial results wellness technology
Last updated: Mar 6, 2025

Biotech snapshot

Cash runway
$10M liquidity · $1M/mo burn
~7 mo
High dilution risk
Lead asset
GammaCorePhase 2
Chronic Cluster Headache →